183 related articles for article (PubMed ID: 21677834)
1. Secretion of melatonin and 6-sulfatoxymelatonin urinary excretion in functional dyspepsia.
Chojnacki C; Poplawski T; Klupinska G; Blasiak J; Chojnacki J; Reiter RJ
World J Gastroenterol; 2011 Jun; 17(21):2646-51. PubMed ID: 21677834
[TBL] [Abstract][Full Text] [Related]
2. Does melatonin homeostasis play a role in continuous epigastric pain syndrome?
Chojnacki C; Poplawski T; Blasiak J; Chojnacki J; Klupinska G
Int J Mol Sci; 2013 Jun; 14(6):12550-62. PubMed ID: 23771022
[TBL] [Abstract][Full Text] [Related]
3. [Excretion and metabolism of dopamine in patients with functional dyspepsia].
Wachowska-Kelly P; Stępień A; Romanowski M; Chojnacki C
Pol Merkur Lekarski; 2016 Apr; 40(238):244-7. PubMed ID: 27137825
[TBL] [Abstract][Full Text] [Related]
4. [Secretion of serotonin and melatonin in patients with functional dyspepsia].
Harasiuk A; Klupińska G; Walecka-Kapica E; Foryś S; Felicka E; Piotrowski W; Chojnacki C
Pol Merkur Lekarski; 2007 May; 22(131):336-40. PubMed ID: 17679362
[TBL] [Abstract][Full Text] [Related]
5. Melatonin may have a role in the pathogenesis of functional dyspepsia in males.
Ermis F; Uyanikoglu A; Akyuz F; Yonal O; Keskin F; Ciftci S; Mungan Z
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4675-8. PubMed ID: 26698268
[TBL] [Abstract][Full Text] [Related]
6. Rome III functional dyspepsia subdivision in PDS and EPS: recognizing postprandial symptoms reduces overlap.
Carbone F; Holvoet L; Tack J
Neurogastroenterol Motil; 2015 Aug; 27(8):1069-74. PubMed ID: 26220647
[TBL] [Abstract][Full Text] [Related]
7. Postoperative elevated cortisol excretion is not associated with suppression of 6-sulfatoxymelatonin excretion.
Derenzo J; Macknight B; DiVittore NA; Bonafide CP; Cronin AJ
Acta Anaesthesiol Scand; 2005 Jan; 49(1):52-7. PubMed ID: 15675982
[TBL] [Abstract][Full Text] [Related]
8. Urinary 6-sulfatoxymelatonin excretion in humans during domestic exposure to 50 hertz electromagnetic fields.
Cocco P; Cocco ME; Paghi L; Avataneo G; Salis A; Meloni M; Atzeri S; Broccia G; Ennas MG; Erren TC; Reiter RJ
Neuro Endocrinol Lett; 2005 Apr; 26(2):136-42. PubMed ID: 15855885
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometric quantification of urinary 6-sulfatoxymelatonin: age-dependent excretion and biological variation.
van Faassen M; van der Veen A; van Ockenburg S; de Jong H; de Vries EGE; Kema IP
Clin Chem Lab Med; 2020 Jul; 59(1):187-195. PubMed ID: 32673281
[TBL] [Abstract][Full Text] [Related]
10. Serum melatonin and urinary 6-sulfatoxymelatonin in major depression.
Crasson M; Kjiri S; Colin A; Kjiri K; L'Hermite-Baleriaux M; Ansseau M; Legros JJ
Psychoneuroendocrinology; 2004 Jan; 29(1):1-12. PubMed ID: 14575725
[TBL] [Abstract][Full Text] [Related]
11. [The assessment of selected personality traits, coping and melatonin nocturnal secretion in patients with functional dyspepsia].
Grzyb J; Wrzesińiska M; Harasiuk A; Chojnacki C; Kocur J
Psychiatr Pol; 2007; 41(3):401-10. PubMed ID: 17900055
[TBL] [Abstract][Full Text] [Related]
12. Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes.
Reutrakul S; Siwasaranond N; Nimitphong H; Saetung S; Chirakalwasan N; Chailurkit LO; Srijaruskul K; Ongphiphadhanakul B; Thakkinstian A
Chronobiol Int; 2017; 34(3):382-392. PubMed ID: 28128991
[TBL] [Abstract][Full Text] [Related]
13. Use of nocturnal melatonin concentration and urinary 6-sulfatoxymelatonin excretion to evaluate melatonin status in children with severe sepsis.
Bagci S; Yildizdas D; Horoz OO; Reinsberg J; Bartmann P; Mueller A
J Pediatr Endocrinol Metab; 2011; 24(11-12):1025-30. PubMed ID: 22308859
[TBL] [Abstract][Full Text] [Related]
14. Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy.
Leger D; Laudon M; Zisapel N
Am J Med; 2004 Jan; 116(2):91-5. PubMed ID: 14715322
[TBL] [Abstract][Full Text] [Related]
15. Serotonin and melatonin secretion and metabolism in patients with liver cirrhosis.
Chojnacki C; Walecka-Kapica E; Klupińska G; Wachowska-Kelly P; Żylińska K; Winczyk K; Chojnacki J
Pol Arch Med Wewn; 2012; 122(9):392-7. PubMed ID: 22814406
[TBL] [Abstract][Full Text] [Related]
16. Daytime 50 Hz magnetic field exposure and plasma melatonin and urinary 6-sulfatoxymelatonin concentration profiles in humans.
Crasson M; Beckers V; Pequeux C; Claustrat B; Legros JJ
J Pineal Res; 2001 Oct; 31(3):234-41. PubMed ID: 11589758
[TBL] [Abstract][Full Text] [Related]
17. Morning urinary assessment of nocturnal melatonin secretion in older women.
Cook MR; Graham C; Kavet R; Stevens RG; Davis S; Kheifets L
J Pineal Res; 2000 Jan; 28(1):41-7. PubMed ID: 10626600
[TBL] [Abstract][Full Text] [Related]
18. Nocturnal secretion of melatonin in patients with upper digestive tract disorders.
Klupińska G; Wiśniewska-Jarosińska M; Harasiuk A; Chojnacki C; Stec-Michalska K; Błasiak J; Reiter RJ; Chojnacki J
J Physiol Pharmacol; 2006 Nov; 57 Suppl 5():41-50. PubMed ID: 17218759
[TBL] [Abstract][Full Text] [Related]
19. Positive effect of daylight exposure on nocturnal urinary melatonin excretion in the elderly: a cross-sectional analysis of the HEIJO-KYO study.
Obayashi K; Saeki K; Iwamoto J; Okamoto N; Tomioka K; Nezu S; Ikada Y; Kurumatani N
J Clin Endocrinol Metab; 2012 Nov; 97(11):4166-73. PubMed ID: 22948764
[TBL] [Abstract][Full Text] [Related]
20. [The influence of melatonin on concentration of nitric oxide metabolites in gastric juice in subjects with functional dyspepsia].
Walecka-Kapica E; Klupińska G; Harasiuk A; Felicka E; Foryś S; Chojnacki C
Pol Merkur Lekarski; 2007 May; 22(131):332-5. PubMed ID: 17679361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
